Lupin receives approval from U.S. FDA for Obeticholic acid tablets

Lupin receives approval from U.S. FDA for Obeticholic acid tablets

The product will be manufactured at Lupin’s Nagpur facility in India.

FPJ Web DeskUpdated: Wednesday, May 31, 2023, 04:10 PM IST
article-image
Lupin receives approval from U.S. FDA for Obeticholic acid tablets | Image: Lupin (Representative)

Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Obeticholic Acid Tablets, 5 mg and 10 mg, a generic equivalent of Ocaliva® Tablets, 5 mg and 10 mg, of Intercept Pharmaceuticals, Inc., the company announced through an exchange filing.

The product will be manufactured at Lupin’s Nagpur facility in India.

Obeticholic Acid Tablets (RLD Ocaliva®) had estimated annual sales of USD 262 million in the U.S. (IQVIA MAT Mar 2023).

Lupin Ltd shares

The Lupin Ltd shares on Wednesday at 3:30 pm IST  were at Rs 806.00, up by 0.30 per cent.

RECENT STORIES

Game-Changing Alliance: Ambani's Reliance Ventures Into Adani's Power For The First Time; Acquires...

Game-Changing Alliance: Ambani's Reliance Ventures Into Adani's Power For The First Time; Acquires...

SRM Contractors IPO Subscribed 86.57 Times On Last Day Of Bidding

SRM Contractors IPO Subscribed 86.57 Times On Last Day Of Bidding

Tax-Saving Tip From Zerodha CEO Nithin Kamath: 'If You're Married And Hindu..."; Here's How To Save...

Tax-Saving Tip From Zerodha CEO Nithin Kamath: 'If You're Married And Hindu...

Holy Cities Like Ayodhya, Varanasi Attracting Big Retail Brands: Report

Holy Cities Like Ayodhya, Varanasi Attracting Big Retail Brands: Report

A Big Relief For Byjus's: NCLT Rejects Investor Plea To Stay Byju's Rights Issue EGM On March 29...

A Big Relief For Byjus's: NCLT Rejects Investor Plea To Stay Byju's Rights Issue EGM On March 29...